Chief of Staff Emeritus and Chairman of the Medical Staff Executive Committee at Dana-Farber Cancer Institute since 1995, Dr. Stephen E. Sallan is a renowned pediatric oncologist and professor at Harvard Medical School. His clinical research focuses on the genetic heterogeneity and treatment of the most common childhood cancer malignancy, acute lymphoblastic lymphoma, to understand disease recurrence and drug resistance, develop new, more specific therapies, and conduct research in diminishing the toxicity of treatment. Current research has expanded investigations to adolescents and young adults with other leukemias and lymphomas.
Dr. Sallan has received the Distinguished Alumni Award from the Wayne State University School of Medicine, the James Carreras Prize for International Pediatrician of the Year, and the Boston Red Sox Biomedical All-Star Award. He received his MD from Wayne State University and completed residencies at the Children’s Hospital of Philadelphia, the Hospital for Sick Children in London and a fellowship in pediatric oncology at the Children’s Hospital Boston and Dana-Farber Cancer Institute.